How Common Gum Disease Bacteria Interact with Colorectal Cancer Cells

Scientific research continues to explore how oral bacteria might influence health conditions elsewhere in the body. A recent laboratory study published in late 2024 investigated the metabolic effects of two common periodontal pathogens—bacteria associated with gum disease—when exposed to human colorectal cancer cells.

The study examined Fusobacterium nucleatum and Porphyromonas gingivalis, both well-known microbes linked to oral infections. Researchers exposed human colorectal cancer cells (specifically the HCT116 cell line) to these two bacterial species for durations of 6 hours and 24 hours. They then used a laboratory technique called quantitative real-time PCR (qPCR) to evaluate changes in the expression levels of specific genes involved in metabolism and detoxification.

What the Study Found

The researchers observed that Fusobacterium nucleatum and Porphyromonas gingivalis triggered distinct, time-dependent metabolic changes in the cancer cells:

• At 6 hours: Fusobacterium nucleatum increased the expression of certain genes involved in the kynurenine pathway (KYNU), lipid metabolism (PLD2 and ACAT1). Conversely, Porphyromonas gingivalis broadly suppressed genes related to polyamine synthesis (SMS), amino acid metabolism (PAH), the kynurenine pathway (KYNU), lipid metabolism (ACAT1), and detoxification (ALDH2).
• At 24 hours: Both bacterial species maintained predominantly suppressive effects on KYNU, SMS, and PAH gene expression.

Additionally, the researchers compared these microbial-induced changes with genetic data from The Cancer Genome Atlas (TCGA). They noted that human colorectal cancer tissues naturally showed downregulation of certain metabolic genes (like ACAT1 and ALDH2) and upregulation of others (like KYNU, PLD2, PAH, and SMS), showing partial overlap with the changes driven by Fusobacterium nucleatum.

Understanding the Limitations

It is important to understand the boundaries of this research. This was strictly a laboratory study conducted on human cancer cell lines, not a clinical trial involving human patients. Laboratory models help scientists observe microscopic and chemical interactions in a controlled environment, but they cannot fully replicate the complex environment of the human body. Furthermore, this study demonstrates an association between bacterial exposure and changes in gene expression; it does not prove that periodontal pathogens directly cause or worsen cancer outcomes in people.

What This Means for Patients

While this study sheds light on the complex interactions between oral bacteria and cancer cells at a cellular level, it does not change everyday dental care or medical advice. It simply adds to the growing body of scientific literature examining how oral microorganisms interact with systemic health. Maintaining good oral hygiene and managing gum disease remain essential for oral health, but patients should view basic laboratory findings as early-stage scientific exploration rather than direct evidence of systemic disease progression.